Skip to main content

Table 3 Demographic, clinical and biochemical characteristics of studied groups

From: The influence of Nrf2 gene promoter methylation on gene expression and oxidative stress parameters in preeclampsia

Variable

Preeclampsiare women (n = 70)

Mean ± SD

Healthy pregnant women (n = 70)

Mean ± SD

P value*

Age (year)

29.56 ± 4.96

28.36 ± 6.37

0.113

Gestational age (week)

35.61 ± 3.56

38.5 ± 1.44

< 0.001

BMI (Kg/m2)

33.17 ± 5.68

29.93 ± 5.16

< 0.001

Systolic Blood Pressure (mmHg)

148.08 ± 17.00

112.85 ± 11.56

< 0.001

Diastolic Blood Pressure (mmHg)

91.66 ± 16.17

70.55 ± 10.52

< 0.001

Birth weight (g)

2622.5 ± 887.8

3390.7 ± 408

< 0.001

AST (IU/L)

28.2 ± 24.9

27.9 ± 12

0.96

ALT (IU/L)

24 ± 46.3

28.2 ± 26.9

0.8

ALP (IU/L)

338 ± 27

444.5 ± 150.8

0.1

Total Bilirubin (mg/dL)

0.62 ± 0.35

0.61 ± 0.17

0.96

Direct Bilirubin (mg/dL)

0.2 ± 0.07

0.19 ± 0.07

0.66

Proteinuria

+

44 (62.8%)

None

< 0.001

++

15 (21.4%)

None

+++

9 (12.9%)

None

++++

2 (2.9%)

None

  1. AST: aspartate transaminase; ALT: alanine transaminase; ALP: alkaline phosphatase
  2. * Independent sample t-test